23rd May 2011 12:11
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of DIRECTOR MR. CHRISTOPHER CORBIN | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF SHARE OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A | 8 | State the nature of the transaction GRANTING OF SHARE OPTIONS |
9 | Number of shares, debentures or financial instruments relating to shares acquired N/A | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
N/A
| 14 | Date and place of transaction 20 MAY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A
| 16 | Date issuer informed of transaction
N/A
|
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant 20 MAY 2011
| 18 | Period during which or date on which it can be exercised FROM 20 MAY 2014 TO 19 MAY 2018 |
19 | Total amount paid (if any) for grant of the option N/A | 20 | Description of shares or debentures involved (class and number) 66,088 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES |
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €0.05 | 22 | Total number of shares or debentures over which options are held following notification 874,117 SHARE OPTIONS OVER ORDINARY SHARES |
23 | Any additional information SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 23/05/2011 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of DIRECTOR MR. LIAM FITZGERALD | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF SHARE OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A | 8 | State the nature of the transaction GRANTING OF SHARE OPTIONS |
9 | Number of shares, debentures or financial instruments relating to shares acquired N/A | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
N/A
| 14 | Date and place of transaction 20 MAY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A
| 16 | Date issuer informed of transaction
N/A |
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant 20 MAY 2011
| 18 | Period during which or date on which it can be exercised FROM 20 MAY 2014 TO 19 MAY 2018 |
19 | Total amount paid (if any) for grant of the option N/A | 20 | Description of shares or debentures involved (class and number) 185,064 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES |
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €0.05 | 22 | Total number of shares or debentures over which options are held following notification 1,703,944 SHARE OPTIONS OVER ORDINARY SHARES |
23 | Any additional information SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 23/05/2011 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of DIRECTOR MR. BARRY MCGRANE | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF SHARE OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A | 8 | State the nature of the transaction GRANTING OF SHARE OPTIONS |
9 | Number of shares, debentures or financial instruments relating to shares acquired N/A | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
N/A
| 14 | Date and place of transaction 20 MAY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A
| 16 | Date issuer informed of transaction
N/A
|
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant 20 MAY 2011
| 18 | Period during which or date on which it can be exercised FROM 20 MAY 2014 TO 19 MAY 2018 |
19 | Total amount paid (if any) for grant of the option N/A | 20 | Description of shares or debentures involved (class and number) 65,800 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES |
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €0.05 | 22 | Total number of shares or debentures over which options are held following notification 879,915 SHARE OPTIONS OVER ORDINARY SHARES |
23 | Any additional information SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 23/05/2011 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of DIRECTOR MR. ALAN RALPH | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF SHARE OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A | 8 | State the nature of the transaction GRANTING OF SHARE OPTIONS |
9 | Number of shares, debentures or financial instruments relating to shares acquired N/A | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
N/A
| 14 | Date and place of transaction 20 MAY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A
| 16 | Date issuer informed of transaction
N/A
|
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant 20 MAY 2011
| 18 | Period during which or date on which it can be exercised FROM 20 MAY 2014 TO 19 MAY 2018 |
19 | Total amount paid (if any) for grant of the option N/A | 20 | Description of shares or debentures involved (class and number) 71,969 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES |
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €0.05 | 22 | Total number of shares or debentures over which options are held following notification 817,266 SHARE OPTIONS OVER ORDINARY SHARES |
23 | Any additional information SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 23/05/2011 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of PERSON DISCHARGING MANAGERIAL RESPONSIBILITY MR. MIKE GANNON | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF SHARE OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A | 8 | State the nature of the transaction GRANTING OF SHARE OPTIONS |
9 | Number of shares, debentures or financial instruments relating to shares acquired N/A | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
N/A
| 14 | Date and place of transaction 20 MAY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A
| 16 | Date issuer informed of transaction
N/A
|
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant 20 MAY 2011
| 18 | Period during which or date on which it can be exercised FROM 20 MAY 2014 TO 19 MAY 2018 |
19 | Total amount paid (if any) for grant of the option N/A | 20 | Description of shares or debentures involved (class and number) 42,640 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES |
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €0.05 | 22 | Total number of shares or debentures over which options are held following notification 236,866 SHARE OPTIONS OVER ORDINARY SHARES |
23 | Any additional information SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 23/05/2011 |
SCHEDULE 11
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
This form is intended for use by an issuer to make a RIS notification required by the Market Abuse Rules and section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990.
(5) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(6) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(7) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(8) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete the boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
All relevant boxes should be completed in block capital letters
1 | Name of the Issuer UNITED DRUG PLC
| 2 | State whether the notification relates to: (i) a transaction notified in accordance with Market Abuse Rules;
(ii) a disclosure made in accordance with section 53 (as extended by section 64 of the Companies Act 1990) or entered into the issuer's register in accordance with section 59 of the Companies Act 1990; or (iii) both (i) and (ii). (iii)
|
3 | Name of PERSON DISCHARGING MANAGERIAL RESPONSIBILITY MR. LIAM LOGUE | 4 | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person N/A |
5 | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest AS PER 3 ABOVE | 6 | Description of shares (including class) debentures or derivatives or financial instruments relating to shares GRANTING OF SHARE OPTIONS RELATING TO ORDINARY SHARES OF €0.05 EACH |
7 | Name of registered shareholder(s) and, if more than one, number of shares held by each of them N/A | 8 | State the nature of the transaction GRANTING OF SHARE OPTIONS |
9 | Number of shares, debentures or financial instruments relating to shares acquired N/A | 10 | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A |
11 | Number of shares, debentures or financial instruments relating to shares disposed N/A
| 12 | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A |
13 | Price per share or value of transaction
N/A
| 14 | Date and place of transaction 20 MAY 2011 |
15 | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A
| 16 | Date issuer informed of transaction
N/A
|
If a person discharging managerial responsibilities has been granted options by the issuer, complete the following boxes:
17 | Date of grant 20 MAY 2011
| 18 | Period during which or date on which it can be exercised FROM 20 MAY 2014 TO 19 MAY 2018 |
19 | Total amount paid (if any) for grant of the option N/A | 20 | Description of shares or debentures involved (class and number) 45,454 NOMINAL VALUE SHARE OPTIONS OVER ORDINARY SHARES |
21 | Exercise price (if fixed at time of grant) or indication that the price is to be fixed at the time of exercise €0.05 | 22 | Total number of shares or debentures over which options are held following notification 539,446 SHARE OPTIONS OVER ORDINARY SHARES |
23 | Any additional information SHARE OPTIONS WILL BE ENTITLED TO DIVIDEND EQUIVALENTS | 24 | Name of contact and telephone number for queries KAREN GEOGHEGAN (01-4637720) |
Name and signature of duly designated officer of issuer responsible for making notification _Karen Geoghegan___________________________________________________ Date of notification 23/05/2011 |
Related Shares:
UDG.L